Co-infection ratios versus inflammation, growth factors and progression of early atheromas

APMIS

Volumn 114, Issue 5, 2006, Pages 338-344

  Higuchi, Maria L ^a,c   Góis, José M ^b   Reis, Marcia M ^a   Higuchi Dos Santos, Marilia H ^a   Diament, Jayme ^a   Sousa, Januário M ^b   Ramires, José A F ^a   Oliveira, Sérgio A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Portuguese Charity Hospital   (Brazil)

^c NONE   (Brazil)

Author keywords

Atherosclerosis; Chlamydophila pneumoniae; Growth factors; Inflammatory cells; Mycoplasma pneumoniae

Indexed keywords

BACTERIAL ANTIGEN; CD68 ANTIGEN; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B;

ADULT; AGED; ARTICLE; ATHEROMA; CELLULAR DISTRIBUTION; CHLAMYDOPHILA PNEUMONIAE; COMPARABLE WORTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MALE; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL; SUPERINFECTION;

EID: 33744810608     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_351.x     Document Type: Article

References (24)

1. Ross R. Atherosclerosis. An inflammatory disease. New Engl J Med 1999 340:115 26.
2. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2004 15:237 54.
3. Rutherford RB Ross R. Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol 1976 69:196 203.
4. Libby P. The vascular biology of atherosclerosis. In:Zipes D Libby P Bonow RO Braunwald E. Braunwald's Heart Disease. 7th ed. Elsevier Saunders:Philadelphia, USA, 2005:921 37.
5. Shor A Phillips JI. Chlamydophila pneumoniae and atherosclerosis. JAMA 1999 282:2071 3.
6. Gupta S Camm AJ. Chronic Infections Chlamydophila pneumoniae and Coronary Heart Disease. The Netherlands:Kluwer Academic Publishers, 1999.
7. O'Connor S Taylor D Campbell LA, et al. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infec Dis 2001 7:780.
8. Mahony JB Coombes BK. Chlamydophila pneumoniae and atherosclerosis: does the evidence support a causal or contributory role? FEMS Microbiol Lett 2001 197:1 9.
9. Higuchi ML Sambaise NV Palomino S Gutierrez P Demarchi L Aiello V Ramires JAF. Detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res 2000 33:1023 6.
10. Higuchi M Reis MM Sambiase NV Palomino SAP Castelli JB Gutierrez PS, et al. Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in ruptured plaques associated with acute myocardial infarction. Arq Bras Cardiol 2003 81:12 22.
11. Van Nerom A Ducatelle R Charlier G Haeseebrouck F. Interaction between turkey monocytes and avian Chlamydia psittaci in the presence of Mycoplasma sp.: the importance of nitric oxide. Dev Comp Immunol 2000 24:417 32.
12. Krausse-Opatz B Schmidt C Fendrich U Bialowons A Kaever V Zeidler H, et al. Production of prostaglandin E2 in monocytes stimulated in vitro by Chlamydia trachomatis, Chlamydophila pneumoniae, and Mycoplasma fermentans. Microb Pathog 2004 37:155 61.
13. Nicholson GL Gan R Haier J. Multiple co-infections (Mycoplasma, Chlamydia, human herpes vírus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS 2003 111:557 66.
14. Vink A Poppen M Schoneveld AH Roholl PJ de Kleijn DP Borst C Pasterkamp G. Distribution of Chlamydophila pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 2001 103:1613 17.
15. Barrett TB Benditt EP. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 1988 85:2810 4.
16. Bezerra HG Higuchi ML Gutierrez OS Palomino AS Silvestre J Libby P, et al. Atheromas that cause fatal thrombosis are usually large and frequently accompanied by vessel enlargement. Cardiovasc Pathol 2001 10:189 96.
17. Inoue I Inaba T Motoyoshi K Harada K Shimano H Kawamura M, et al. Macrophage colony stimulating factor prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 1992 93:245 54.
18. Nykanen AI Krebs R Tikkanen JM Raisky O Sihvola R Wood J, et al. Combined vascular endothelial growth factor and platelet derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation 2005 79:182 9.
19. Into T Nodasaka Y Hasebe A Okuzawa T Nakamura J Ohata N, et al. Mycoplasmal lipoproteins induce toll-like receptor 2- and caspases-mediated cell death in lymphocytes and monocytes. Microbiol Immunol 2002 46:265 76.
20. Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev 2003 83:417 32.
21. Prochnau D Rodel J Hartmann M Straube E Figulla HR. Growth factor production in human endothelial cells after Chlamydophila pneumoniae infection. Int J Med Microbiol 2004 294:53 7.
22. Dunbar LM. Current issues in the management of bacterial respiratory tract disease: the challenge of antibactrial resistance. Am J Med Sci 2003 326:360 8.
23. Hammerschlag MR. Advances in the management of Chlamydophila pneumoniae infections. Expert Rev Anti Infect Ther 2003 1:493 503.
24. Kutlin A Kohlhoff S Roblin P Hammerschlag MR Riska P. Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis. Antimicrob Agents Chemother 2005 49:903 7.